Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream, covering 2022-04-01 to 2022-04-01. Get the full timeline:
Most recent: Clinical Trial Update: Multicenter Study to Assess the Efficacy and Safety of Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) Versus Vehicle Cream for Actinic Keratosis of the Face [Phase 3]